Page 3 - Adrian Quartel News Today

The FDA has granted Breakthrough Therapy designation to Edsivo (celiprolol) for the treatment of patients with COL3A1-positive vEDS.

Industry veteran with over 20 years of drug development experience to oversee advancement of Acer’s product pipeline...

More OFF Time and Dyskinesia Education Needed, Survey Suggests Adamas Pharmaceuticals Inc launches the education campaign “Picture More Time” in response to a survey suggesting the need for education in the Parkinson’s community about OFF time and dyskinesia. An Incomplete Understanding The survey, co-sponsored by the Parkinson & Movement Disorder Alliance (PMD Alliance) and Adamas, received 775 respondents, including 527 people with PD and 248 care partners. Seventy-eight percent of thos...

FDA approves new indication for Adamas’ Gocovri in Parkinson’s disease Gocovri approved to treat patients with Parkinson’s disease experiencing OFF episodes The US Food and Drug Administration (FDA) has approved Adamas Pharmaceuticals’ Gocovri for a new indication in patients with Parkinson’s disease experiencing OFF episodes. The FDA has approved Gocovri (amantadine) as an adjunctive treatment to levodopa/carbidopa, a commonly-used treatment for the main symptoms of Parkinson’s d...

Piper Sandler Expands Investment Banking with the Hiring of Treavor Hill Piper Sandler Expands Investment Banking with the Hiring of Treavor Hill Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Treavor Hill as a managing director within the firms investment banking group. He will focus on the automotive and commercial vehicle aftermarkets and will be based in the firms Minneapolis office. Hill has over 10 years of investment banking expe...